This inventor holds 1 USPTO granted patent. Top assignee: Calth. Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Cheon Jung Kim: Innovator in Lateral Flow Assay Technology
Introduction
Cheon Jung Kim is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of biomedical diagnostics, particularly through his innovative work on lateral flow assay technology. His expertise and dedication to advancing medical testing methods have positioned him as a key figure in this area.
Latest Patents
Cheon Jung Kim holds a patent for a "Concentration kit for lateral flow assay strip." This invention provides a lateral flow assay method and strip wherein a sample is injected into a sample pad. A preconcentration kit is coupled to the sample pad to preconcentrate analytes. Additionally, a conjugate pad or a test pad is connected to the sample pad to transfer the analytes, allowing for the detection of biomarkers present at low concentrations. This innovation enhances the sensitivity and accuracy of diagnostic tests.
Career Highlights
Cheon Jung Kim is associated with Calth Inc., where he continues to develop and refine his inventions. His work has been instrumental in improving diagnostic methodologies, making them more efficient and reliable. With a focus on practical applications, he aims to bridge the gap between laboratory research and real-world medical diagnostics.
Collaborations
Cheon Jung Kim collaborates with talented professionals in his field, including Jeong Hoon Lee and Yong Kyoung Yoo. These partnerships foster a creative environment that encourages the exchange of ideas and the development of cutting-edge technologies.
Conclusion
Cheon Jung Kim's contributions to the field of lateral flow assay technology exemplify his commitment to innovation in biomedical diagnostics. His work not only advances scientific knowledge but also has the potential to improve patient outcomes through enhanced diagnostic capabilities.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile